Title:
化合物及びその使用
Document Type and Number:
Japanese Patent JP2010531292
Kind Code:
A
Abstract:
Formula (I) below: and their pharmaceutically acceptable salts or tautomers, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of at least one symptom or condition associated with schizophrenia and other psychotic disorders, dementia and other cognitive disorders, anxiety disorders, mood disorders, sleep disorders, disorders usually first diagnosed in infancy, childhood, or adolescence and neurodegenerative disorders.
Inventors:
Peter Bernstein
James Bee Campbell
James Bee Campbell
Application Number:
JP2009543161A
Publication Date:
September 24, 2010
Filing Date:
December 19, 2007
Export Citation:
Assignee:
ASTRAZENECA AKTIEBOLAG
International Classes:
C07D281/16; A61K31/554; A61K45/00; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28
Domestic Patent References:
| JPH04211071A | 1992-08-03 | |||
| JPS638378A | 1988-01-14 |
Foreign References:
| WO2005002586A1 | 2005-01-13 | |||
| US20060063754A1 | 2006-03-23 |
Other References:
JPN6013005282; Ｊ． Ｍｅｄ． Ｃｈｅｍ． Ｖｏｌ．４４, 2001, Ｐ．３７２-３８９
Attorney, Agent or Firm:
Junji Yuda
Shoji Miwa
Noriyuki Takebayashi
Chika Takagi
Shoji Miwa
Noriyuki Takebayashi
Chika Takagi